A randomized, open-label study of therapy with PEGASYS vs Roferon-A, both with ribavirin + amantadine, on sustained virological response in patients with chronic hepatitis C viral infection unresponsive to standard therapy with interferon alpha plus ribavirin.
Phase of Trial: Phase IV
Latest Information Update: 02 Jun 2010
At a glance
- Drugs Amantadine; Interferon alpha-2a; Peginterferon alfa-2a; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- Acronyms BeTTy
- Sponsors Roche
- 19 Feb 2008 New trial record.